Shortly after WuXi AppTec provided an upbeat outlook for 2025, several other WuXi sibling companies are coming forward with ...

India and the US are set to increase market access and improve bilateral trade by reducing tariffs and enhancing supply chain ...

President Trump dubbed April 2 as 'Liberation Day' when all his tariff plans will be revealed. Advisors offer their views on ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

President Donald Trump on Monday announced the United States will impose a 25% tariff on the imports of any country involved ...

International private equity firm Cinven has completed its previously announced sale of an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, ...

The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced that Novo Nordisk and TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) ...

Investing.com -- U.S. stocks edged higher Tuesday, continuing the recent positive tone on hopes that the Trump administration ...

Investing.com - Futures tied to Canada’s main stock index pointed slightly higher on Tuesday, as investors eyed the outlook for U.S. President Donald Trump’s tariff plans. By 06:48 ET (10:48 GMT), the ...

The FTSE 100 and European markets ticked higher at the opening bell, even as president Donald Trump rolled out fresh threats ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeli ...